Normalization of serum free light chains during therapy in the MM5 trial predicts prolonged progression free survival and overall survival

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2019-10, Vol.19 (10), p.e208-e208
Main Authors: Haas, Eva-Maria, Salwender, Hans J., Mai, Elias K., Dürig, Jan, Weisel, Katja, Tichy, Diana, Benner, Axel, Kunz, Christina, Hielscher, Thomas, Bertsch, Uta, Besemer, Britta, Merz, Maximilian, Munder, Markus, Lindemann, Hans-Walter, Hügle-Dörr, Barbara, Giessen, Nicola, Hose, Dirk, Seckinger, Anja, Huhn, Stefanie, Luntz, Steffen, Jauch, Anna, Elmaagacli, Ahmet, Rabold, Bernhard, Fuhrmann, Stephan, Brossart, Peter, Goerner, Martin, Bernhard, Helga, Hoffmann, Martin, Hillengass, Jens, Raab, Marc S., Blau, Igor Wolfgang, Haenel, Mathias, Scheid, Christof, Goldschmidt, Hartmut
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
DOI:10.1016/j.clml.2019.09.346